GlassScriptPhysician profile
Tracy P Nogle
NPI 1831625805
$1,961.78
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $855 · 2023: $854 · 2024: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $410.71 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $320.47 | 2022-2023 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $153.65 | 2021-2023 | Breztri, Farxiga |
| Pfizer INC. | $153.54 | 2022-2023 | |
| Glaxosmithkline, LLC. | $126.64 | 2022-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $118.03 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $103.41 | 2021-2023 | |
| Dynavax Technologies Corporation | $95.87 | 2021-2023 | Heplisav-B |
| Biohaven Pharmaceutical Holding Company LTD. | $55.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $47.09 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $46.50 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Antares Pharma, INC. | $44.49 | 2022-2023 | Tlando, Xyosted, Nocdurna |
| Exact Sciences Corporation | $32.84 | 2023 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $31.49 | 2022-2023 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.40 | 2023 | Jardiance |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $22.12 | 2022 | |
| Allergan, INC. | $19.35 | 2022 | |
| Idorsia Pharmaceuticals US INC | $18.81 | 2023 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $18.65 | 2021 | |
| Bioventus LLC | $16.67 | 2024 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $16.65 | 2022 | |
| Depuy Synthes Sales INC. | $16.46 | 2024 | Monovisc, Orthovisc |
| Janssen Scientific Affairs, LLC | $14.35 | 2021 | |
| Sanofi Pasteur INC. | $13.97 | 2023 | |
| Vistapharm, INC. | $13.54 | 2021 | |
| Reel Surgical, INC. | $13.31 | 2024 | |
| Merck Sharp & Dohme LLC | $13.29 | 2023 | Steglujan, Segluromet, Steglatro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Nogle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.